NCT02307396View on ClinicalTrials.gov

Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 1, 2015

Primary Completion Date

June 22, 2016

Study Completion Date

June 22, 2016

Conditions

SchizophreniaSchizophrenia and Disorders With Psychotic FeaturesSchizoaffective Disorders

Interventions

DRUG

Olanzapine

DRUG

Amisulpride

DRUG

Risperidone

DRUG

Haloperidol

DRUG

Quetiapine

DRUG

Perphenazine

DRUG

Sulpiride

DRUG

bromperidol

DRUG

Zuclopenthixol

DRUG

Thioridazine

DRUG

Paliperidone

DRUG

Ziprasidone

DRUG

Benperidol

DRUG

Fluspirilene

DRUG

Pimozide

DRUG

Perazine

DRUG

Fluphenazine

DRUG

Flupentixole

DRUG

Sertindole

Trial Locations (1)

81675

Psychiatrische Klinik und Poliklinik fuer Psychiatrie und Psychotherapie der Technischen Universitaet Muenchen am Klinikum rechts der Isar, Munich

All Listed Sponsors

lead

Technical University of Munich

OTHER

NCT02307396 - Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients | Biotech Hunter | Biotech Hunter